- 12 oral surgery updates in 2026
- 5 ASC, MOB deals in California
- Hidden OR capacity challenges: 8 perioperative leaders on what’s draining surgical time
- The Aspen Group’s 3-year growth recap: 40 moves
- Florida State University set to acquire Tallahassee hospital
- How Confusing Financial Journeys Undermine Revenue and Trust
- How Confusing Financial Journeys Undermine Revenue and Trust
- Misalignment, Not Malice: Rethinking Generational Conflict in Healthcare
- If AI ‘adds friction, it fails’: How Mayo Clinic scales technology
- As maternity units close, AdventHealth restores OB care in rural Kansas
- Oklahoma officials warn of new opioid
- The new metrics of healthcare technology ROI: What matters to healthcare leaders
- Hoag to launch transplant center in 2027
- MercyOne hospital to transition labor and delivery services
- MercyOne hospital to transition labor and delivery services
- Southeast metros lead US population growth as national gains slow
- 8 Medicare Advantage numbers to know in 2026
- 17 Senate Dems push back on 2027 ACA proposal
- Providence hospital closes inpatient pediatric unit
- Michigan finalizes Medicaid mental health assessment policy changes
- 10 financial notes on USPI’s growth over the past 3 years
- 15 new orthopedic practice, center openings in Q1
- The oral surgery technological revolution
- From Anxiety to Action: How Ambulatory Leaders Are Rebuilding Margins in 2026
- Where GI training may fall short
- What it took to become the world’s first ASC to offer Stryker’s robotic knee tech
- Medtronic’s win in spinal cord stimulator lawsuit upheld
- How the Trump Administration Uses Migrant Kids To Find and Detain Family Members
- Heartland Dental’s 3-year growth recap: 30+ moves
- Cencora’s $10B+ physician acquisition spree: A breakdown
- Tennessee physician practice acquired
- The FTC is coming for healthcare consolidation: 10 things physicians need to know
- Adventist Health sees momentum from insourcing revenue cycle operations
- Oral GLP-1s, COVID preventatives: 3 more drugs in the pipeline, Optum says payers should watch
- Unlicensed dentistry cases, DSO deals, legislation & more: 10 dentistry updates in Virginia
- Missouri system debuts mobile behavioral health unit
- Yale researchers study GLP-1’s potential for SUD
- Texas dental school receives $6.5M to expand pediatric dental, medical programs
- North Carolina autism provider to expand therapy access
- $3M Verdict Links Social Media to Anxiety and Depression
- West Virginia hospital to end OB delivery services
- 6 DSOs making headlines
- California hospital’s finances improve, cash position remains ‘dire’
- 1 in 5 metro markets face inpatient monopoly: 7 notes
- Minnesota system faces uncertainty amid Medicare delays
- Ohio county approves behavioral health crisis center plan
- The White House Delays CDC Pick
- New COVID 'Cicada' Variant Is Spreading — What Experts Want You To Know
- Op-ed: Empathy meets efficiency—how the responsible use of AI can transform Medicare
- Family Caregivers Provide $1 Trillion In Annual Labor, AARP Says
- ‘Health Doesn’t Need to Be Ludacris’: Bayer signs rapper-actor to multivitamin campaign
- Rocket plots measured trajectory for new gene therapy Kresladi after clearance to launch from FDA
- Healthy Lab Results May Mask Future Risks for Kids with Obesity
- At-Home Chemotherapy Is Safe, Feasible, Pilot Study Indicates
- What You Do While Sitting Could Predict Dementia Risk
- New Cholesterol Guidelines: What Patients and Caregivers Need to Know
- Want A Bootlicking Yes Man? Ask An AI Chatbot For Advice, Study Warns
- Specially Coated Implants Better For Breast Cancer Patients, Study Finds
- Trump Team Claims Successes Against ACA Fraud While Pushing for More Controls
- Give and Take: Federal Rural Health Funding Could Trigger Service Cuts
- Fierce Pharma Asia—Takeda’s $1.3B reorg; India’s GLP-1 floodgates; Gilead’s $2.2B buy of a China NewCo
- Where are you with EUDAMED?
- Where are you with EUDAMED?
- HL7 Launches Real‑Time Medical Device Interoperability Accelerator
- HL7 Launches Real‑Time Medical Device Interoperability Accelerator
- Two GA Tech ATDC Startups — Nephrodite and OrthoPreserve — Secure FDA Breakthrough Device Designation
- Two GA Tech ATDC Startups — Nephrodite and OrthoPreserve — Secure FDA Breakthrough Device Designation
- Artificial Intelligence: ROI, not Clinical Autonomy, Leads Operational Workflows
- Artificial Intelligence: ROI, not Clinical Autonomy, Leads Operational Workflows
- Medtronic and Merit Medical Systems distribution agreement for new, ViaVerte basivertebral nerve ablation system
- Medtronic and Merit Medical Systems distribution agreement for new, ViaVerte basivertebral nerve ablation system
- Breakthrough Device Designation for Noah Labs Vox Heart Failure Detection Device
- Breakthrough Device Designation for Noah Labs Vox Heart Failure Detection Device
- Why private practice dentistry needs a better model
- CareQuest Innovation Partners, Kno2 collab on medical-dental data integration
- Nonprofit highlights rural opioid care strategies
- Vitana Pediatric & Orthodontic Partners adds Florida practice
- What the Health? From KFF Health News: A Headless CDC
- 20 behavioral health leaders challenge industry assumptions
- Recordati confirms it's weighing CVC Capital buyout offer of $12.6B
- 3 California behavioral health centers to close amid funding shifts
- Indiana bars autism therapy provider from Medicaid billing: Wall Street Journal
- UnitedHealth shareholder sues over proposal to include details on integration in annual proxy
- SCAN taps biopharma, CMS vet Aman Bhandari as its first chief AI officer
- Infosys to acquire Optimum Healthcare IT in $465M deal
- DOJ alleges NewYork-Presbyterian forces payers into anticompetitive 'all-or-nothing' contracts
- FDA Warns Biotech Firm Over Cancer Drug Anktiva Claims
- Bees and Hummingbirds May Be Consuming Small Amounts of Alcohol
- Two States Sue Cord Blood Company Over Misleading Claims
- New WHO Guidance Aims To Speed Tuberculosis Testing
- As questions swirl around ATTR competition, Alnylam plots path to market leadership for Amvuttra
- Trump admin delays nomination for new CDC director past deadline
- Outspoken ACIP member steps down amid vaccine panel uncertainty: reports
- Egg-based drugmaker Neion Bio emerges from stealth to cook up multi-product biosimilar collab
- Genentech walks the walk in lupus as sponsor of annual awareness and fundraising event
- Study Reveals How Many Americans Consider Using a Gun
- Massive Study Finds Stress and Grief Don’t Cause Cancer
- Ultra-Processed Foods Harm Fertility In Both Men And Women, Studies Reveal
- Small Daily Habits Can Add Up To Better Heart Health
- Ritalin Might Protect ADHD Kids' Long-Term Mental Health, Study Finds
- Can You Drink Enough Fluids To Prevent Kidney Stones? Maybe Not, New Study Says
- Clasp, loan-linked hiring tool for employers, clinches $20M to expand amid federal loan caps
- Taking a GLP-1? Doctors Say Not To Forget About Movement and Mental Health
- OpenEvidence rolls out AI medical coding feature
- CDC’s Acting Chief Promises a Return to Stability in a Tumultuous Moment
- Remarks at the Financial Stability Oversight Council Meeting
- RWJF: Between 5M and 10M people could lose Medicaid coverage in 2028 under work requirements
- New therapy animal program aims to support 100K patients, providers
- Pulse check on Lilly's GLP-1 fortunes
- Gen Z nurses prioritize schedule flexibility, need more manager interactions to avoid turnover
- How pharma marketers can capitalize on HCPs’ AI, social media and streaming habits
- Federal Officials Investigate States That Require Abortion Coverage
- Corcept's lead drug bounces back from FDA snub with different approval as Lifyorli in ovarian cancer
- Ionis slashes Tryngolza's price tag by 93% ahead of anticipated label expansion
- FDA approves Denali's Hunter syndrome drug, handing rare disease community a win
- Baby Walkers Sold on Amazon Recalled Over Fall Risk
- Want To Protect Your Brain? Science Says Exercise
- HelloFresh Pizza Recall Issued in 10 States Over Metal Risk
- Clinical Trials Have Too Much Data…That’s the Problem.
- Clinical Trials Have Too Much Data…That’s the Problem.
- CMS reveals new Medicaid model that supports coordination for children with complex needs
- Novartis sued by breast cancer patient over branded drug websites’ data-sharing practices
- Takeda targets $1.3B in cost savings in further restructuring
- Biogen pays $20M upfront to tap into Alteogen's subQ delivery tech
- 'Universal Donor' Blood Supplies Dangerously Low, Study Warns
- Why Stepping Outside May Help You Eat Better
- U.S. Medicine, Science Facing An Online Misinformation Siege, Poll Concludes
- Childhood Obesity Undercuts The American Dream For Some, Study Says
- Inclusive High Schools Benefit All Students, Not Just LGBTQ Teens
- Parental Loss Due to Drugs, Violence Raises Child Death Risk by 2,000%
- As Boehringer touts US launches, board chairman worries EU is 'falling further behind'
- The evolving state of exome and genome sequencing
- Demoralized CDC Workforce Reels From Year of Firings, Funding Cuts, and a Shooting
- An Arm and a Leg: Steep Health Care Costs Steer Americans to Tough Decisions
- Qualified Health locks in $125M in fresh funding to scale enterprise AI at health systems
- Misery Loves [Investment] Company?: Remarks at the 2026 Investment Company Institute Investment Management Conference
- Study: Nearly 1 in 5 pediatric hospital deaths involve sepsis
- As expansions come online, CDMO Hovione aims to meet industry's 'dual supply and sourcing' zeal: exec
- Opening Remarks at the Digital Asset Summit 2026
- CVS Caremark, FTC reach settlement in insulin pricing case
- UCB unveils plan to build $2B biologics plant near its US headquarters in Atlanta
- PeaceHealth sued over plans to tap out-of-state staffer ApolloMD for Oregon EDs
- New Lyme Disease Vaccine Shows Strong Results in Trial
- TrumpRx Adds Diabetes, COPD Drugs at Steep Discounts
- Highmark reports $175M net loss for 2025 as financial headwinds batter health plan
- Listen to the Latest ‘KFF Health News Minute’
- Abivax hires commercial chief from Takeda to infuse Entyvio expertise into IBD launch prep
- ImmunityBio hit with FDA warning letter over Anktiva promotions in TV ad, podcast episode
- Alcohol Prep Pads Recalled Over Bacteria Risk, Cardinal Health Says
- Fewer patients traveled for abortions in 2025 as telehealth care increased, report finds
MSN reports potential UHC Group shareholder insurrection/accountability at its 2025 Annual Meeting. Of the two named leaders, one is from the far Left. (I don't know about the Sisters of the Holy Names of Jesus and Mary of Quebec.)
Trillium Asset Management lists its headquarters in Boston, MA, but according to Morgan Stanley is a subsidiary of Perpetual Limited (“Perpetual”), an Australian-listed diversified financial services firm, and a part of Perpetual’s multi-boutique global asset management business.
Trillium functions in 38 states including Michigan, and manages $5.0 billion according to Investor.com.
It describes its founder, Joan Bavaria (1943-2008), as the "Founding Mother" of ESG Investing.
Trillium is a political activist. Business for America: "Trillium is a responsible investment firm that offers ESG strategies and services to advance a global sustainable economy and a just society. Learn how Trillium supports democracy, voting rights, and civic engagement through its business practices and engagements."
Shareholders urge UnitedHealth to analyze impact of healthcare denials
January 9, 2024NEW YORK / BOSTON (Reuters) - UnitedHealth Group shareholders on Wednesday said they requested the company prepare a report on the costs and public health impact related to its "practices that limit or delay access to healthcare."
If the proposal makes it to a vote at the company's annual meeting it would raise a charged topic after a senior executive was gunned down in Manhattan last month.
A spokesperson for UnitedHealth said the company will respond to shareholder proposals for its 2025 proxy statement once it files the document that serves as an agenda for its annual meeting, which has not yet been scheduled. In recent years, the company has issued its proxy in April ahead of a June annual meeting.
Those who filed the resolution include religious groups led by the Sisters of the Holy Names of Jesus and Mary of Quebec, and Trillium Asset Management.
The group proposed an analysis of how prior authorization, or approval required by an insurer before a patient can receive medical care, and denials of medical services lead patients to forgo treatment.
“The pattern of delays and denials of necessary medical care by UnitedHealth and other insurance companies harms more than just the patient themselves,” Wendell Potter, president of the Center for Health & Democracy and a former Cigna executive, said in a statement sent in support of the resolution by the Interfaith Center on Corporate Responsibility.
UnitedHealth runs the country's largest health insurer, UnitedHealthcare, as well as pharmacy benefit manager Optum and medical practices.
The killing of UnitedHealthcare CEO Brian Thompson in December galvanized criticism of U.S. health insurers, with swarms of patients describing delayed or denied care and accusing companies of using deceptive practices.
Luigi Mangione, 26, who was accused of killing Thompson, pleaded not guilty in a New York court in December after receiving thousands of dollars in public donations shortly after his arrest.
In a December statement, UnitedHealth said it approves and pays for an average of 90% of medical claims submitted.
"Highly inaccurate and grossly misleading information has been circulated about our company’s treatment of insurance claims," UnitedHealth said.
UnitedHealth CEO Andrew Witty in a message to employees described Thompson as "one of the good guys," adding the company would continue to service the most vulnerable Americans.
(Reporting by Amina Niasse in New York and Ross Kerber in Boston; editing by Caroline Humer and Bill Berkrot)
The Hill reports further details, including many co-filers in the proposal.
https://thehill.com/policy/healthcare/5074769-unitedhealth-denied-care-uhg-brian-thompson/?
UnitedHealth shareholders demand review of policies that ‘delayed or denied’ health care access
Shareholders of UnitedHealth Group (UHG) are calling on the company’s board of directors to release a report on how its policy of limiting or delaying access to health care may be impacting the company’s brand and the economy overall.The proposal by shareholders asked that the UHG board of directors produce a report looking into “how company practices impact access to healthcare and patient outcomes, including analyses of how often prior authorization requirements or denials of coverage lead to delay or abandonment of medical treatment and serious adverse events for patients.”
In a supporting statement, the shareholders said UHG policies that cause “delayed or avoided medical care” threaten both the company brand name as well as its investors’ portfolios by “increasing consumer debt, jeopardizing health of policyholders and thereby reducing workforce productivity, straining government resources, and risking increased taxes.”
Sisters of the Holy Names of Jesus and Mary led the filing. Co-filers include: Benedictine Sisters of Baltimore – Emmanuel Monastery; Benedictine Sisters of Mount St. Scholastica; Mercy Investment Services; Sisters of St. Francis of Philadelphia; Sisters of the Humility of Mary, OH; and Trillium Asset Management.
When reached for a response, a UHG spokesperson declined to specifically comment on this proposal, directing inquiries to a statement the company issued last month regarding “misinformation.” UHG said it approves and pays 90 percent of medical claims upon submission.
“Highly inaccurate and grossly misleading information has been circulated about our company’s treatment of insurance claims,” the statement read.
The company’s claim process came under congressional scrutiny last year, with a Senate report finding that UnitedHealthcare and other major health insurers denied post-acute care services for Medicare Advantage at “substantially higher rates” than prior authorization requests for other types of care.
“The data provided by the companies show that, not only did insurers deny prior authorization for postacute care more often than other services, but that the rate of denial was substantially higher for some companies,” the report found.
“For UnitedHealthcare and CVS, 2022 denial rates for prior authorization of post-acute care services were approximately three times higher than the companies’ overall denial rates. In the case of Humana, rates for 2022 were over 16 times higher.”
Timnit Ghermay, director of Northwest Coalition for Responsible Investment (NWCRI), led the filing of the proposal. Ghermay cited the recent killing of UnitedHealthcare CEO Brian Thompson in a statement explaining the request.
“UNH has been in the media and legislative spotlight for some time given its market dominance, aggressive marketing of Medicare Advantage and questionable use of AI algorithms to deny care to patients,” Ghermay said. “As the tragic murder of UNH’s Brian Thompson made evident, public outrage over the exorbitant costs and restricted access to healthcare has reached a dangerous level in our country.”
The NWCRI is part of the Interfaith Center on Corporate Responsibility (ICCR), which describes itself as a “coalition of faith- and values-based investors.” The ICCR has previously filed proposals for UHG to produce reports explaining its use of artificial intelligence as well as racial disparities within the company.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.

















